Beranda › Astrositoma › Utah › Salt Lake City
Uji klinis Astrositoma di Salt Lake City, UT
5 studi untuk Astrositoma mencari peserta di lokasi sekitar Salt Lake City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Menerima pesertaFase 3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Menerima pesertaFase 1/2
- Huntsman Cancer Institute, Salt Lake City
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Menerima pesertaFase 1
- Huntsman Cancer Institute/University of Utah, Salt Lake City
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Menerima pesertaFase 3
- Huntsman Cancer Insititute, University of Utah, Salt Lake City
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Menerima pesertaFase 1
- University of Utah, Huntsman Cancer Institute, Salt Lake City
Uji klinis Astrositoma di kota lain
- Houston, TX14 studi
- Boston, MA13 studi
- Chicago, IL9 studi
- New York City, NY9 studi
- Miami, FL7 studi
- Philadelphia, PA7 studi
- Columbus, OH6 studi
- San Francisco, CA6 studi
- Washington, DC6 studi
- Durham, NC6 studi
- Seattle, WA6 studi
- Cincinnati, OH5 studi
Studi lain di Salt Lake City
- Kanker Paru Non-Sel Kecil31 studi
- Kanker (semua jenis)27 studi
- Kanker Payudara27 studi
- Kanker Kolorektal22 studi
- Kanker Paru21 studi
- Melanoma21 studi
- Mieloma Multipel21 studi
- Kanker Metastatik20 studi
- Kanker Ovarium19 studi
- Obesitas18 studi
- Leukemia Mieloid Akut17 studi
- Gagal Jantung17 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.